Acrospire Investment Management’s Integra LifeSciences IART Stock Holding History

Acrospire Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,900	Closed	-$104K	–	677
2017 Q2	$104K	Buy	1,900 +1,400	+280%	+$66.9K	0.1%	227
2017 Q1	$21K	Sell	500 -2,900	-85%	-$124K	0.02%	1597
2016 Q4	$146K	Buy	3,400 +400	+13%	+$16.3K	0.06%	631
2016 Q3	$124K	Buy	3,000 +1,200	+67%	+$50.3K	0.08%	381
2016 Q2	$72K	Buy	1,800 +200	+13%	+$7.2K	0.05%	772
2016 Q1	$54K	Buy	+1,600	New	+$49.8K	0.04%	871

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acrospire Investment Management's IART Position: Q3 2017 in Review

Acrospire Investment Management sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 1,900 shares — an estimated $104K sold.

Acrospire Investment Management first reported a position in IART in Q1 2016 and held it in 6 quarters. The position peaked at $146K in Q4 2016. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

Acrospire Investment Management reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
Acrospire Investment Management sold 1,900 Integra LifeSciences shares in Q3 2017, an estimated $104K.
Acrospire Investment Management first reported a position in Integra LifeSciences in Q1 2016 and held it in 6 quarters.
Acrospire Investment Management's Integra LifeSciences position peaked at $146K in Q4 2016.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.